Brief: Plant Advanced Technologies says PAT1657 proved potential to treat skin inflammation pathologies
19/06/2017 07:01
June 19 (Reuters) - PLANT ADVANCED TECHNOLOGIES PAT SA
ALPAT.PA
* PAT1657 (PATENT PENDING) PROVED ITS POTENTIAL TO TREAT
SKIN INFLAMMATION PATHOLOGIES
* PLANT ADVANCED TECHNOLOGIES PAT SA- RESULTS FOR THIS API
SHOW STRONG EFFICACY FOR CHRONIC INFLAMMATION AND PSORIASIS ON
MICE MODELS WITHOUT SIDE EFFECTS COMPARED TO MARKET REFERENCE IN
CORTICOSTEROIDS
Source text for Eikon: ID:nBw2CfZP3a
Further company coverage: ALPAT.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Plant Advanced Technologies Pat SA
See all newsBrief: Consortium Made Up Of PAT, Etap-Lab, Laboratory Of University Of Lorraine Announces Official Launch Of Bryoflam Project
Brief: PAT Group, Fytexia Launch Partnership Around N'GINS Program
Brief: PAT Group End-June Net Loss Group Share Stable At EUR 1.1 Mln
Brief: PAT Group FY Operating Loss Widens To EUR 2.1 Mln
Brief: PAT Group FY Turnover Up At EUR 2.3 Mln